000			01573 a2200493 4500
005			20250512022809.0
264		0	_c19850729
008			198507s 0 0 eng d
022			_a0140-6736
024	7		_a10.1016/s0140-6736(85)91784-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aLucarelli, G
245	0	0	_aMarrow transplantation for thalassaemia following busulphan and cyclophosphamide. _h[electronic resource]
260			_bLancet (London, England) _cJun 1985
300			_a1355-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aActuarial Analysis
650	0	4	_aAge Factors
650	0	4	_aBone Marrow Transplantation
650	0	4	_aBusulfan _xtherapeutic use
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCombined Modality Therapy
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGraft vs Host Disease _xepidemiology
650	0	4	_aHistocompatibility Testing
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aMale
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aThalassemia _xtherapy
700	1		_aPolchi, P
700	1		_aGalimberti, M
700	1		_aIzzi, T
700	1		_aDelfini, C
700	1		_aManna, M
700	1		_aAgostinelli, F
700	1		_aBaronciani, D
700	1		_aGiorgi, C
700	1		_aAngelucci, E
773	0		_tLancet (London, England) _gvol. 1 _gno. 8442 _gp. 1355-7
856	4	0	_uhttps://doi.org/10.1016/s0140-6736(85)91784-2 _zAvailable from publisher's website
999			_c2867157 _d2867157